Aprameya Engineering Ltd vs Clinitech Laboratory Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Aprameya Engineering Ltd is ₹ 89.9 as of 23 Oct 15:30 . The P/E Ratio of Aprameya Engineering Ltd is 12.1 as of March 2025 .The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 . The Market Cap of Aprameya Engineering Ltd is ₹ 194.97 crore as of March 2025 .The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 . The Dividend Payout of Aprameya Engineering Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aprameya Engineering Ltd

Aprameya Engineering Limited was originally formed as a partnership firm in the name and style of 'M/s.
Aprameya Engineering' pursuant to a Deed of Partnership dated September 05, 2003, registered as on August 13, 2004 at Ahmedabad.
Subsequently, Company incorporated pursuant to a Certificate of Incorporation dated December 28, 2021 issued by the Registrar of Companies, following the conversion of Partnership Firm 'M/s.
Aprameya Engineering' to a Private Limited Company.
Further, Company converted into a Public Limited Company and its name was changed from 'Aprameya Engineering Private Limited' to 'Aprameya Engineering Limited' vide a fresh Certificate of Incorporation upon conversion dated May 12, 2022, issued by the Registrar of Companies, Ahmedabad. Company is a trusted partner in India's healthcare infrastructure space, with over two decades of experience in delivering turnkey hospital projects and integrated medical technology solutions across public and private sectors.

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

FAQs for the comparison of Aprameya Engineering Ltd and Clinitech Laboratory Ltd

Which company has a larger market capitalization, Aprameya Engineering Ltd or Clinitech Laboratory Ltd?

Market cap of Aprameya Engineering Ltd is 171 Cr while Market cap of Clinitech Laboratory Ltd is 7 Cr

What are the key factors driving the stock performance of Aprameya Engineering Ltd and Clinitech Laboratory Ltd?

The stock performance of Aprameya Engineering Ltd and Clinitech Laboratory Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aprameya Engineering Ltd and Clinitech Laboratory Ltd?

As of October 24, 2026, the Aprameya Engineering Ltd stock price is INR ₹89.9. On the other hand, Clinitech Laboratory Ltd stock price is INR ₹32.0.

How do dividend payouts of Aprameya Engineering Ltd and Clinitech Laboratory Ltd compare?

To compare the dividend payouts of Aprameya Engineering Ltd and Clinitech Laboratory Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.